THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE

THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE

Show other versions (1)

<p>A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally different mechanisms of action, is presented in patients with chronic heart failure (CHF) on the base of GISSI-HF and SHIFT trails results. It is essential to compaire an effect of these drugs on the...

Full description

Bibliographic Details
Main Authors:	S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	хроническая сердечная недостаточность рандомизированное клиническое исследование ивабрадин омега-3 полиненасыщенные жирные кислоты
Online Access:	http://www.rpcardio.ru/jour/article/view/561

Similar Items

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015-12-01)

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
by: A. O. Malygin, et al.
Published: (2015-09-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS AND COGNITIVE DEVELOPMENT OF CHILDREN
by: O. A. Gromova, et al.
Published: (2011-01-01)

Omega-3 polyunsaturated fatty acids in cardiology
by: N. V. Perova
Published: (2005-08-01)

PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
by: V. P. Mikhin, et al.
Published: (2017-12-01)

COMPOSITION OF LIPIDS AND FATTY ACIDS IN MUSCLE TISSUE OF CHUB MACKEREL SCOMBER JAPONICUS
by: L. V. Shulgina, et al.
Published: (2019-03-01)

Ivabradine therapy effectiveness in patients with chronic heart failure, Functional Class III
by: S. G. Kanorskiy, et al.
Published: (2011-04-01)

Are There the Antiarrhythmic Effects of Omega3 Polyunsaturated Fatty Acids in Cardiosurgical Patients?
by: V. V. Lomivorotov, et al.
Published: (2014-10-01)

Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year
by: N. G. Gogolashvili, et al.
Published: (2011-10-01)

ИССЛЕДОВАНИЕ АНТИАРИТМИЧЕСКИХ ЭФФЕКТОВ ОМЕГА-3 ПОЛИНЕНАСЫЩЕННЫХ ЖИРНЫХ КИСЛОТ В КАРДИОХИРУРГИИ. ДАННЫЕ ИМПЛАНТИРУЕМОГО МОНИТОРА РИТМА СЕРДЦА
by: С. М. Ефремов, et al.
Published: (2015-10-01)

Lipoxygenation of fatty acids in plants
by: A. B. Golovanov, et al.
Published: (2008-12-01)

Role of omega-3 polyunsaturated fatty acids in cardiovascular risk management
by: V. I. Podzolkov, et al.
Published: (2020-07-01)

Blubber fatty acids of marine and freshwater seals.
by: E. S. Averina, et al.
Published: (2009-06-01)

Complex processing of lipids from liver of the gonatid squid <i>Berryteuthis magister </i>
by: Ekaterina V. Ermolenko, et al.
Published: (2014-03-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

Options of dyslipidemia treatment at non-alcoholic fatty liver disease
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

STUDY OF THE LEVEL OF FATTY ACIDS IN ERYTHROCYTE MEMBRANES AND SERUM OF PATIENTS WITH COLORECTAL CANCER IN NOVOSIBIRSK
by: M. V. Kruchinina, et al.
Published: (2018-07-01)

Omega-3 index of erythrocytes and predictors of sudden cardiac death in patients with coronary heart disease and ventricular arrhythmias
by: E. M. Gavva, et al.
Published: (2012-08-01)

Многоцентровое исследование эффективности препарата комбинированной терапии Серетид Мультидиск у пациентов со средне-тяжелой бронхиальной астмой
Published: (2018-06-01)

Bisoprolol and sotalol for maintaining sinus rhythm in patients with paroxysmal atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2005-12-01)

Canned goods from pacific saury - a source of polyunsaturated fatty acids of the omega-3 family
by: Lidia V. Shulgina, et al.
Published: (2017-12-01)

Platelet aggregation, dyslipoproteinemia and polyunsaturated fatty acids
by: E. I. Sokolov, et al.
Published: (2006-10-01)

ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE
by: M. V. Surovtseva, et al.
Published: (2015-12-01)

Indapamide retard in complex therapy of patients with chronic heart failure and arterial hypertension
by: S. N. Tereshchenko, et al.
Published: (2010-04-01)

Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01)

Pathogenesis of chronic heart failure: change of dominating paradigm
by: V. V. Kalyuzhin, et al.
Published: (2007-12-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
by: M. V. Melnik, et al.
Published: (2015-12-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

LONG-TERM EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION AT THE BACKGROUND OF MULTIPLE-VESSEL LESION CORONARY ATHEROSCLEROSIS
by: M. N. Sin’kova, et al.
Published: (2014-12-01)

Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity
by: S. N. Tereshchenko, et al.
Published: (2009-10-01)

EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE
by: V. N. Larina, et al.
Published: (2016-01-01)

Hypertensive encephalopathy, heart remodeling, and chronic heart failure
by: L. A. Geraskina, et al.
Published: (2006-06-01)

Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction
by: S. A. Sayganov, et al.
Published: (2010-06-01)

HYPERURICEMIA AS A PREDICTOR OF CHRONIC HEART FAILURE
by: M. V. Ledyakhova, et al.
Published: (2015-09-01)

USAGE OF MODERN VITAMIN-MINERAL COMPLEXES AS SUPPLEMENTARY SOURCE OF ESSENTIAL POLYUNSATURATED FATTY ACIDS IN PEDIATRIC PRACTICE
by: A. A. Trubnikov, et al.
Published: (2013-02-01)

Physical training – modulator of peripheral factors for chronic heart failure development
by: A. S. Noskova, et al.
Published: (2007-02-01)

The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE
by: L. N. Maksimova, et al.
Published: (2015-09-01)